Category: Uncategorized

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

| May 13, 2024

 Read More  

Vivani Medical to Present at TIDES Conference 2024

| May 9, 2024

 Read More  

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

| March 26, 2024

 Read More  

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

| March 6, 2024

 Read More  

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

| March 1, 2024

 Read More  

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

| February 28, 2024

 Read More  

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

| November 14, 2023

 Read More  

Vivani Medical to Present at BIO Investor Forum

| October 16, 2023

 Read More  

Vivani Medical to Present at the Boulder Peptide Symposium

| September 7, 2023

 Read More  

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

| September 5, 2023

 Read More